AGNT An-Con Genetics Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AGNT An-Con Genetics Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Skywatcher who wrote (1)	3/9/1998 10:52:00 PM
From: Marshall	Read Replies (1) of 24

The company is actually making a profit and growing too. Picked this up out of the last earnings report: J. Robert Saron, chairman of An-Con, stated, "We continue to direct much effort in strengthening our financial infrastructure, by closely monitoring inventory and expenses, as well as placing greater emphasis on higher profit margin segments of the company's businesses. Furthermore, while we experienced an increase in costs relating to sales, the results are very encouraging, particularly in the area of electro-surgery. Management is optimistic that we will begin to witness the positive impact of our new products in fiscal year 1998." An-Con Genetics Inc. through its wholly-owned subsidiary, Aaron Medical Industries Inc., is engaged in the manufacturing and marketing of a diverse line of premium medical devices and proprietary tissue fixatives. The last earns were reported November 18, how often do these companies report?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next